HIT Screening

ABLINK offers a high-throughput affinity screening platform consisting of antigen design and expression, bio-panning, and positive clone identification. We also provide a variety of customized screening strategies, such as functional screening, to meet the different needs of our clients.

Service Projects

Virtual panning of AI drug libraries

AI-driven fully synthetic libraries panning

Panning of ‘300-billion-level’ diversity antibody library

Alpaca and camel immunization and nanobody discovery

Functional antibodies developed by microfluidic technology

Antibody blocking peptides/Probody discovery

PH-sensitive antibody discovery

Endocytic antibody discovery

Design and expression of antigen epitope peptides and complex structure

Technical Advantages

1. AI-driven virtual screening helps the elimination of drug molecules with poor druggability and high immunogenicity

2. High success rate of screening, screening success rate of ABLINK's own fully synthetic library can reach 90%.

3. Our customizable screening strategies can satisfy different customers’ needs.